Key result
Arteriovenous access significantly affects cardiovascular hemodynamics in dialysis patients, requiring individualized access selection based on cardiac status to prevent heart failure exacerbation.
Why the study?
Arterio-venous access is associated with improved survival but may affect heart function and worsen clinical status in some chronic kidney disease patients.
This review highlights the cardiovascular hemodynamic effects of arterio-venous access in dialysis patients and provides individualized recommendations for vascular access selection to mitigate risks such as high-output heart failure.
AV fistula may worsen heart function in select dialysis patients; leaves open optimal access selection and cardiac monitoring strategies.
Chronic kidney disease is associated with increased cardiovascular morbidity and mortality. A well-functioning vascular access is associated with improved survival and among the available types of vascular access the arterio-venous (AV) fistula is the one associated with the best outcomes. However, AV access may affect heart function and, in some patients, could worsen the clinical status. This review article focuses on the specific cardiovascular hemodynamics of dialysis patients and how it is affected by the AV access; the effects of an excessive increase in AV access flow, leading to high-output heart failure; congestive heart failure in CKD patients and the contraindications to AV access; pulmonary hypertension. In severe heart failure, peritoneal dialysis (PD) might be the better choice for cardiac health, but if contraindicated suggestions for vascular access selection are provided based on the individual clinical presentation. Management of the AV access after kidney transplantation is also addressed, considering the cardiovascular benefit of AV access ligation compared to the advantage of having a functioning AVF as backup in case of allograft failure. In PD patients, who need to switch to hemodialysis, vascular access should be created timely. The influence of AV access in patients undergoing cardiac surgery for valvular or ischemic heart disease is also addressed. Cardiovascular implantable electronic devices are increasingly implanted in dialysis patients, but when doing so, the type and location of vascular access should be considered.
No takes yet. Share an insight, caveat, or question.
Malík et al. (2020) conducted a review in End-stage renal disease. Arteriovenous access was evaluated. Arteriovenous access significantly affects cardiovascular hemodynamics in dialysis patients, requiring individualized access selection based on cardiac status to prevent heart failure exacerbation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: